Radionetics Oncology
Menlo Park, US · Founded 2021 · Delaware corporation · 2 known investors
Founders & leadership
BE
Brett EwaldExecutive
UG
Umesh GangadharmathExecutive
IM
Istvan MolnarExecutive
YZ
Yunfei ZhuExecutive
AK
Ana KusnetzowExecutive
SS
Scott StruthersNamed on SEC filing
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$54.2M disclosed across 1 round · 2023
▶$54.2MraisedAug 2023 · 6 investors · PharmaceuticalsRule 506(b)
▶$54.2MraisedAug 2023 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brett EwaldExecutive Officer
- Andrew SchwabDirector
- Umesh GangadharmathExecutive Officer
- Dan EstesExecutive Officer, Director
- Istvan MolnarExecutive Officer
- Yunfei ZhuExecutive Officer
- Ana KusnetzowExecutive Officer
- Scott StruthersDirector
- Offering amount
- $68.7M
- Amount sold
- $54.2M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Radionetics Oncology's investors?
- Radionetics Oncology's investors include DCVC (Data Collective), Frazier Life Sciences.
- How much funding has Radionetics Oncology raised?
- Radionetics Oncology has disclosed $54.2M raised across 1 round.
- Where is Radionetics Oncology headquartered?
- Radionetics Oncology is headquartered in Menlo Park, US.